Intelligence Feed event · Equity · 2026-10-06

    Microfluidics Diagnostics Market Projected to Reach $48B by 2036 on Consumables

    Question

    Microfluidics Diagnostics Market Projected to Reach $48B by 2036 on Consumables

    Direct answer

    Long-term structural demand for rapid point-of-care testing, decentralized clinical diagnostics, and automated genomic analysis is expanding the global microfluidics industry. The market is projected to reach $48.04 billion by 2036, growing at a 7.49% CAGR from $21.58 billion in 2025. With consumable chips and reagent cartridges generating 66.7% of market revenues, life science tool makers benefit from a recurring razor-and-blade model that insulates cash flows from broader capital equipment spending volatility.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-06
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Microfluidics Diagnostics Market Projected to Reach $48B by 2036 on Consumables”, revision 1, evidence through 2026-10-06. https://marketontology.com/market-events/2026-10-06/microfluidics-diagnostics-market-projected-to-reach-48b-by-2036-on-consumables-09f6a0

    EQUITY
    Microfluidics Diagnostics Market Projected to Reach $48B by 2036 on Consumables
    Long-term structural demand for rapid point-of-care testing, decentralized clinical diagnostics, and automated genomic analysis is expanding the global microfluidics industry. The market is projected to reach $48.04 billion by 2036, growing at a 7.49% CAGR from $21.58 billion in 2025. With consumable chips and reagent cartridges generating 66.7% of market revenues, life science tool makers benefit from a recurring razor-and-blade model that insulates cash flows from broader capital equipment spending volatility.
    TMODHR
    Impact
    57
    OCT 6
    SIG
    80%
    TMODHR
    Microfluidics Diagnostics Market Projected to Reach $48B by 2036 on Consumables
    Long-term structural demand for rapid point-of-care testing, decentralized clinical diagnostics, and automated genomic analysis is expanding the global microfluidics industry. The market is projected to reach $48.04 billion by 2036, growing at a 7.49% CAGR from $21.58 billion in 2025. With consumable chips and reagent cartridges generating 66.7% of market revenues, life science tool makers benefit from a recurring razor-and-blade model that insulates cash flows from broader capital equipment spending volatility.
    → Expansion of decentralized diagnostic workflows drives high-margin consumable cartridge volumes across life science tool providers TMO, DHR, and ILMN.
    Impact
    Long-term structural demand for rapid point-of-care testing, decentralized clinical diagnostics, and automated genomic analysis is expanding the global microfluidics industry. The market is projected to reach $48.04 billion by 2036, growing at a 7.49% CAGR from $21.58 billion in 2025. With consumable chips and reagent cartridges generating 66.7% of market revenues, life science tool makers benefit from a recurring razor-and-blade model that insulates cash flows from broader capital equipment spending volatility.
    Affected
    TMODHR
    Transmission
    Expansion of decentralized diagnostic workflows drives high-margin consumable cartridge volumes across life science tool providers TMO, DHR, and ILMN.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    TMOrecurring diagnostic consumables volume supporting life science tools revenueWatch1-3mSource identifies Thermo Fisher Scientific among primary entities exposed to microfluidics growth.
    DHRpoint-of-care diagnostic automation recurring consumables margin supportWatch1-3mSource identifies Danaher as a key participant in the growing microfluidics consumables market.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month